Antiadenovirus activities of several classes of nucleoside and nucleotide analogues

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 3, 2005, Pages 1010-1016

  Naesens, L ^a   Lenaerts, L ^a   Andrei, G ^a   Snoeck, R ^a   Van Beers, D ^b   Holý, Antonin ^c   Balzarini, Jan ^a   De Clercq, Erik ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^c INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 7 [(1,3 DIHYDROXY 2 PROPOXY)METHYL]PURINE; 2,4 DIAMINO 6 [3 HYDROXY 2 (PHOSPHONOMETHOXY)PROPOXY]PYRIMIDINE; 3' FLUOROTHYMIDINE; 5 (2 BROMOVINYL) 2' DEOXYURIDINE; 9 (3 HYDROXY 2 PHOSPHONOMETHOXYPROPYL)ADENINE; 9 [1,2 BIS(HYDROXYMETHYL)CYCLOPROPYLMETHYL]GUANINE; ACICLOVIR; ANTIVIRUS AGENT; CIDOFOVIR; DNA POLYMERASE; FOSCARNET; FOSCARNET SODIUM; GANCICLOVIR; LAMIVUDINE; NUCLEOSIDE DERIVATIVE; NUCLEOTIDE DERIVATIVE; PENCICLOVIR; RIBAVIRIN; THYMIDINE KINASE; UNCLASSIFIED DRUG; VIRUS DNA; ZALCITABINE; ZIDOVUDINE;

ADENOVIRUS; ANTIVIRAL ACTIVITY; ARTICLE; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; EMBRYO; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS INFECTION; VIRUS REPLICATION; WESTERN BLOTTING;

ADENOVIRIDAE; ANTIVIRAL AGENTS; GANCICLOVIR; HUMANS; NUCLEOSIDES; NUCLEOTIDES; POLYMERASE CHAIN REACTION; THYMIDINE KINASE;

EID: 14744267233     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.3.1010-1016.2005     Document Type: Article

References (29)

1. Andrei, G., R. Snoeck, D. Reymen, C. Liesnard, P. Goubau, J. Desmyter, and E. De Clercq. 1995. Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus. Eur. J. Clin. Microbiol. Infect. Dis. 14:318-328.
2. Baba, M., S. Mori, S. Shigeta, and E. De Clercq. 1987. Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2′-norcyclic GMP on adenovirus replication in vitro. Antimicrob. Agents Chemother. 31:337-339.
3. Bordigoni, P., A. S. Carret, V. Venard, F. Witz, and A. Le Faou. 2001. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin. Infect. Dis. 32:1290-1297.
4. Bruno, B., T. Gooley, R. C. Hackman, C. Davis, L. Corey, and M. Boeckh. 2003. Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival. Biol. Blood Marrow Transplant. 9:341-352.
5. Chuah, M. K., D. Collen, and T. VandenDriessche. 2003. Biosafety of adenoviral vectors. Curr. Gene Ther. 3:527-543.
6. Crumpacker, C. S. 1996. Ganciclovir. N. Engl. J. Med. 335:721-729.
7. Daluge, S. M., D. J. Purifoy, P. M. Savina, M. H. St. Clair, N. R. Parry, I. K Dev, P. Novak, K. M. Ayers, J. E. Reardon, G. B. Roberts, J. A. Fyfe, M. R. Blum, D. R. Averett, R. E. Dornsife, B. A. Domin, R. Ferone, D. A. Lewis, and T. A. Krenitsky. 1994. 5-Chloro-2′,3′-dideoxy-3′- fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile. Antimicrob. Agents Chemother. 38:1590-1603.
8. Degrève, B., M. Johansson, E. De Clercq, A. Karlsson, and J. Balzarini. 1998. Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK. J. Virol. 72:9535-9543.
9. Gavin, P. J., and B. Z. Katz. 2002. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics 110:1-8.
10. Gordon, Y. J., E. G. Romanowski, and T. Araullo-Cruz. 1994. Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model. Investig. Ophthalmol. Vis. Sci. 35:4135-4143.
11. Hillenkamp, J., T. Reinhard, R. S. Ross, D. Böhringer, O. Cartsburg, M. Roggendorf, E. De Clercq, E. Godehardt, and R. Sundmacher. 2002. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology 109:845-850.
12. Hoffman, J. A., A. J. Shah, L. A. Ross, and N. Kapoor. 2001. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 7:388-394.
13. Holý, A., I. Votruba, M. Masojidkova, G. Andrei, R. Snoeck, L. Naesens, E. De Clercq, and J. Balzarini. 2002. 6-[2-(Phosphonomethoxy)alkoxy] pyrimidines with antiviral activity. J. Med. Chem. 45:1918-1929.
14. Iwayama, S., N. Ono, Y. Ohmura, K. Suzuki, M. Aoki, H. Nakazawa, M. Oikawa, T. Kato, M. Okunishi, Y. Nishiyama, and K. Yamanishi. 1998. Antiherpesvirus activities of (1′S,2′R)-9-{[1′,2′- bis(hydroxymethyl)cyclo-prop-1′-yl]methyl}guanine (A-5021) in cell culture. Antimicrob. Agents Chemother. 42:1666-1670.
15. Kaneko, H., K. Kato, S. Mori, and S. Shigeta. 2001. Antiviral activity of NMSO3 against adenovirus in vitro. Antivir. Res. 52:281-288.
16. Lankester, A. C., B. Heemskerk, E. C. Claas, M. W. Schilham, M. F. Beersma, R. G. Bredius, M. J. van Tol, and A. C. Kroes. 2004. Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clin. Infect. Dis. 38:1521-1525.
17. Legrand, F., D. Berrebi, N. Houhou, F. Freymuth, A. Faye, M. Duval, J. F. Mougenot, M. Peuchmaur, and E. Vilmer. 2001. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant. 27:621-626.
18. Ljungman, P., P. Ribaud, M. Eyrich, S. Matthes-Martin, H. Einsele, M. Bleakley, M. Machaczka, M. Bierings, A. Bosi, N. Gratecos, C. Cordonnier, and Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. 2003. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 31:481-486.
19. Mentel, R., M. Kinder, U. Wegner, M. von Janta-Lipinski, and E. Matthes. 1997. Inhibitory activity of 3′-fluoro-2′ deoxythymidine and related nucleoside analogues against adenoviruses in vitro. Antivir. Res. 34:113-119.
20. Neyts, J., and E. De Clercq. 2001. Efficacy of 2-amino-7-(1,3-dihydroxy- 2-propoxymethyl)purine for treatment of vaccinia virus (orthopoxvirus) infections in mice. Antimicrob. Agents Chemother. 45:84-87.
21. Neyts, J., J. Balzarini, G. Andrei, Z. Chaoyong, R. Snoeck, A. Zimmermann, T. Mertens, A. Karlsson, and E. De Clercq. 1998. Intracellular metabolism of the N7-substituted acyclic nucleoside analog 2-amino-7-(1,3- dihydroxy-2-propoxymethyl)purine, a potent inhibitor of herpesvirus replication. Mol. Pharmacol. 53:157-165.
22. Rasool, N. B., S. S. Monroe, and R. I. Glass. 2002. Determination of a universal nucleic acid extraction procedure for PCR detection of gastroenteritis viruses in faecal specimens. J. Virol. Methods 100:1-16.
23. Shigeta, S., K. Konno, M. Baba, T. Yokota, and E. De Clercq. 1991. Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro. J. Infect. Dis. 163:270-275.
24. Sircar, S., A. Ruzindana-Umunyana, W. Neugebauer, and J. M. Weber. 1998. Adenovirus endopeptidase and papain are inhibited by the same agents. Antivir. Res. 40:45-51.
25. Tollefson, A. E., T. W. Hermiston, and W. S. M. Wold. 1999. Preparation and titration of CsCl-banded adenovirus stock, p. 1-9. In W. S. M. Wold (ed.), Adenovirus methods and protocols. Humana Press, Totowa, N.J.
26. Trousdale, M. D., P. L. Goldschmidt, and R. Nobrega. 1994. Activity of ganciclovir against human adenovirus type-5 infection in cell culture and cotton rat eyes. Cornea 13:435-439.
27. Van der Vliet, P. C., and M. M. Kwant. 1981. Role of DNA polymerase gamma in adenovirus DNA replication. Mechanism of inhibition by 2′,3′- dideoxynucleoside 5′-triphosphates. Biochemistry 20:2628-2632.
28. Walls, T., A. G. Shankar, and D. Shingadia. 2003. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet. Infect. Dis. 3:79-86.
29. Wildner, O., D. Hoffmann, C. Jogler, and K. Uberla. 2003. Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs. Cancer Gene Ther. 10:791-802.